Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate.

[1]  M. Réfrégiers,et al.  Photosensitizer effects on cancerous cells: a combined study using synchrotron infrared and fluorescence microscopies. , 2008, Biochimica et biophysica acta.

[2]  M. Gasparetto,et al.  Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies , 2007, Leukemia.

[3]  E. Tschen,et al.  Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12‐month follow up , 2006, The British journal of dermatology.

[4]  C. Eaves,et al.  Chronic Myeloid Leukemia Stem Cells Possess Unique Properties That Predict Intrinsic and Acquired Resistance to Imatinib Mesylate. , 2006 .

[5]  Philip J Rosenfeld,et al.  Ranibizumab: Phase III clinical trial results. , 2006, Ophthalmology clinics of North America.

[6]  D. Chorvat,et al.  Characterization of the Interaction of Hypericin with Protein Kinase C in U-87 MG Human Glioma Cells , 2006, Photochemistry and photobiology.

[7]  C. Eaves,et al.  A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts , 2006, Bone Marrow Transplantation.

[8]  J. Bourhis,et al.  Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia. , 2005, Cancer genetics and cytogenetics.

[9]  M. Réfrégiers,et al.  Fluorescence Spectroscopic Study of Hypericin-photosensitized Oxidation of Low-density Lipoproteins , 2005, Photochemistry and photobiology.

[10]  Gary C. Brown,et al.  The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration--a value-based reappraisal with 5-year data. , 2005, American journal of ophthalmology.

[11]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[12]  M. Guillier,et al.  Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia. , 2004, Biochemical and biophysical research communications.

[13]  J. Bourhis,et al.  Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation , 2004, British Journal of Cancer.

[14]  S. Pereira,et al.  Photodynamic therapy for pancreatic carcinoma: experimental and clinical studies. , 2004, Photodiagnosis and photodynamic therapy.

[15]  Michael R Hamblin,et al.  Photodynamic therapy: a new antimicrobial approach to infectious disease? , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[16]  D. Ross,et al.  Cancer treatment with kinase inhibitors: what have we learnt from imatinib? , 2004, British Journal of Cancer.

[17]  T. Holyoake,et al.  Is there a cloud in the silver lining for imatinib? , 2003, British Journal of Cancer.

[18]  M. Olivo,et al.  Efficacy of hypocrellin pharmacokinetics in phototherapy. , 2002, International journal of oncology.

[19]  J. Goldman,et al.  Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs , 2002, Leukemia.

[20]  G. Jundt,et al.  Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. , 2002, Planta medica.

[21]  M. Olivo,et al.  Hypericin and hypocrellin induced apoptosis in human mucosal carcinoma cells. , 2001, Journal of photochemistry and photobiology. B, Biology.

[22]  P. Rehak,et al.  Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma. , 2001, The Annals of thoracic surgery.

[23]  M. Vicente.  Porphyrin-based sensitizers in the detection and treatment of cancer: recent progress. , 2001, Current medicinal chemistry. Anti-cancer agents.

[24]  J. Zhang,et al.  Photodynamic effects of hypocrellin A on three human malignant cell lines by inducing apoptotic cell death. , 1998, Journal of photochemistry and photobiology. B, Biology.

[25]  B. Balda,et al.  Treatment of cutaneous T-cell lymphoma with extracorporeal photochemotherapy , 1997 .

[26]  M. Ochsner.  Photophysical and photobiological processes in the photodynamic therapy of tumours. , 1997, Journal of photochemistry and photobiology. B, Biology.

[27]  John Tulip,et al.  UPTAKE KINETICS AND INTRACELLULAR LOCALIZATION OF HYPOCRELLIN PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY: A CONFOCAL MICROSCOPY STUDY , 1995, Photochemistry and Photobiology.

[28]  Z. Diwu.  NOVEL THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF HYPOCRELLINS AND HYPERICINS , 1995, Photochemistry and photobiology.

[29]  E. Cao,et al.  DNA damage induced by hypocrellin-A photosensitization. , 1992, International journal of radiation biology.

[30]  J. Lown,,et al.  HYPOCRELLINS and THEIR USE IN PHOTOSENSITIZATION * , 1990, Photochemistry and photobiology.

[31]  Use of photodynamic therapy in the treatment of vocal cord carcinoma. , 1990, Journal of photochemistry and photobiology. B, Biology.

[32]  D. Nachbaur,et al.  Combination effects of human recombinant interferon (alpha-2-arg, gamma) and cytotoxic agents on colony formation of human melanoma and hypernephroma cell lines. , 1989, Cancer letters.

[33]  C. Longsheng,et al.  Effect of hypocrellin A sensitization on the lateral mobility of cell membrane proteins. , 1988 .

[34]  Cheng Ls,et al.  [DNA single-strand breakage and its rejoining in HeLa cells caused by hypocrellin A photosensitization]. , 1988 .

[35]  E. Cao,et al.  [DNA single-strand breakage and its rejoining in HeLa cells caused by hypocrellin A photosensitization]. , 1988, Shi yan sheng wu xue bao.

[36]  L. Cheng,et al.  Effect of hypocrellin A sensitization on the lateral mobility of cell membrane proteins. , 1988, Journal of photochemistry and photobiology. B, Biology.

[37]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[38]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.